Sfoglia per Autore
Interaction between corticosteroids and muscarinic antagonists in human airways
2016-01-01 Cazzola, M; Calzetta, L; Rogliani, P; Puxeddu, E; Facciolo, F; Matera, M
Airflow obstruction: Is it asthma or is it COPD?
2016-01-01 Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M
Olodaterol + tiotropium bromide for the treatment of COPD
2016-04-01 Calzetta, L; Ciaprini, C; Puxeddu, E; Cazzola, M
Dual bronchodilation and exacerbations of COPD
2016-09-01 Cazzola, M; Ora, J; Puxeddu, E
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects?
2017-01-01 Liccardi, G; Calzetta, L; Salzillo, A; Puxeddu, E; Rogliani, P
Optimizing drug delivery in COPD: The role of inhaler devices
2017-01-01 Rogliani, P; Calzetta, L; Coppola, A; Cavalli, F; Ora, J; Puxeddu, E; Matera, M; Cazzola, M
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
2017-01-01 Calzetta, L; Puxeddu, E; Rogliani, P
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment
2017-01-01 Calzetta, L; Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M; Matera, M
Impact of pulmonary vascular volume on mortality in IPF: Is it time to reconsider the role of vasculature in disease pathogenesis and progression?
2017-01-01 Puxeddu, E; Cavalli, F; Pezzuto, G; Teodori, E; Rogliani, P
Adherence to COPD treatment: Myth and reality
2017-01-01 Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis
2018-01-01 Rogliani, P; Matera, Mg; Puxeddu, E; Mantero, M; Blasi, F; Cazzola, M; Calzetta, L
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
2018-01-01 Cazzola, M; Rogliani, P; Puxeddu, E; Ora, J; Matera, Mg
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study
2018-01-01 Rogliani, P; Ora, J; Puxeddu, E; Calzetta, L; Cavalli, F; Matera, Mg; Cazzola, M
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD
2018-02-15 Shute, Jk; Puxeddu, E; Calzetta, L
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD
2018-03-05 Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M
A potential role of triple therapy for asthma patients
2019-01-01 Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
2019-01-01 Rogliani, P; Matera, Mg; Page, C; Puxeddu, E; Cazzola, M; Calzetta, L
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations
2019-01-01 Rogliani, P; Matera, Mg; Ritondo, Bl; De Guido, I; Puxeddu, E; Cazzola, M; Calzetta, L
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone
2019-01-01 Harari, S; Caminati, A; Confalonieri, M; Poletti, V; Vancheri, C; Pesci, A; Rogliani, P; Luppi, F; Agostini, C; Rottoli, P; Sanduzzi Zamparelli, A; Sebastiani, A; Della Porta, R; Salton, F; Messore, B; Tomassetti, S; Rosso, R; Biffi, A; Puxeddu, E; Cerri, S; Cinetto, F; Refini, Rm; Bocchino, M; Di Michele, L; Specchia, C; Albera, C
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
2019-01-01 Cazzola, M; Puxeddu, E; Ora, J; Rogliani, P
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2016 | Interaction between corticosteroids and muscarinic antagonists in human airways | Cazzola, M; Calzetta, L; Rogliani, P; Puxeddu, E; Facciolo, F; Matera, M | Articolo su rivista | |
1-gen-2016 | Airflow obstruction: Is it asthma or is it COPD? | Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M | Articolo su rivista | |
1-apr-2016 | Olodaterol + tiotropium bromide for the treatment of COPD | Calzetta, L; Ciaprini, C; Puxeddu, E; Cazzola, M | Articolo su rivista | |
1-set-2016 | Dual bronchodilation and exacerbations of COPD | Cazzola, M; Ora, J; Puxeddu, E | Articolo su rivista | |
1-gen-2017 | Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? | Liccardi, G; Calzetta, L; Salzillo, A; Puxeddu, E; Rogliani, P | Articolo su rivista | |
1-gen-2017 | Optimizing drug delivery in COPD: The role of inhaler devices | Rogliani, P; Calzetta, L; Coppola, A; Cavalli, F; Ora, J; Puxeddu, E; Matera, M; Cazzola, M | Articolo su rivista | |
1-gen-2017 | Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine | Calzetta, L; Puxeddu, E; Rogliani, P | Articolo su rivista | |
1-gen-2017 | LABA/LAMA combination in copd: A meta-analysis on the duration of treatment | Calzetta, L; Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M; Matera, M | Articolo su rivista | |
1-gen-2017 | Impact of pulmonary vascular volume on mortality in IPF: Is it time to reconsider the role of vasculature in disease pathogenesis and progression? | Puxeddu, E; Cavalli, F; Pezzuto, G; Teodori, E; Rogliani, P | Articolo su rivista | |
1-gen-2017 | Adherence to COPD treatment: Myth and reality | Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M | Articolo su rivista | |
1-gen-2018 | Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis | Rogliani, P; Matera, Mg; Puxeddu, E; Mantero, M; Blasi, F; Cazzola, M; Calzetta, L | Articolo su rivista | |
1-gen-2018 | An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? | Cazzola, M; Rogliani, P; Puxeddu, E; Ora, J; Matera, Mg | Articolo su rivista | |
1-gen-2018 | Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study | Rogliani, P; Ora, J; Puxeddu, E; Calzetta, L; Cavalli, F; Matera, Mg; Cazzola, M | Articolo su rivista | |
15-feb-2018 | Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD | Shute, Jk; Puxeddu, E; Calzetta, L | Articolo su rivista | |
5-mar-2018 | A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD | Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M | Articolo su rivista | |
1-gen-2019 | A potential role of triple therapy for asthma patients | Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P | Articolo su rivista | |
1-gen-2019 | Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine | Rogliani, P; Matera, Mg; Page, C; Puxeddu, E; Cazzola, M; Calzetta, L | Articolo su rivista | |
1-gen-2019 | Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations | Rogliani, P; Matera, Mg; Ritondo, Bl; De Guido, I; Puxeddu, E; Cazzola, M; Calzetta, L | Articolo su rivista | |
1-gen-2019 | The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone | Harari, S; Caminati, A; Confalonieri, M; Poletti, V; Vancheri, C; Pesci, A; Rogliani, P; Luppi, F; Agostini, C; Rottoli, P; Sanduzzi Zamparelli, A; Sebastiani, A; Della Porta, R; Salton, F; Messore, B; Tomassetti, S; Rosso, R; Biffi, A; Puxeddu, E; Cerri, S; Cinetto, F; Refini, Rm; Bocchino, M; Di Michele, L; Specchia, C; Albera, C | Articolo su rivista | |
1-gen-2019 | Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers | Cazzola, M; Puxeddu, E; Ora, J; Rogliani, P | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile